Pellegrino Pionati, See Remarks at Alliqua BioMedical, Inc. (ALQA), bought 50,000 shares at $0.40 ($20K) on 2017-04-03, disclosed to the SEC on 2017-04-04.
Open-market purchase of $20k ALQA by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.